Skip to main content
SpringerLink
Log in

Dopamine agonists cost effective for cotherapy of Parkinson's disease?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dopamine agonists cost effective for cotherapy of Parkinson's disease?. Pharmacoecon. Outcomes News 332, 9 (2001). https://doi.org/10.1007/BF03269623

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03269623

Keywords

Search

Navigation